Mammosphere Formation Assay from Human Breast Cancer Tissues and Cell Lines
Citations Over TimeTop 10% of 2015 papers
Abstract
Similar to healthy tissues, many blood and solid malignancies are now thought to be organised hierarchically, with a subset of stem-like cancer cells that self-renew while giving rise to more differentiated progeny. Understanding and targeting these cancer stem cells in breast cancer, which may possess enhanced chemo- and radio-resistance compared to the non-stem tumor bulk, has become an important research area. Markers including CD44, CD24, and ALDH activity can be assessed using fluorescence activated cell sorting (FACS) to prospectively isolate cells that display enhanced tumorigenicity when implanted into immunocompromised mice: the mammosphere assay has also become widely used for its ability to retrospectively identify sphere-forming cells that develop from single stem cell-like clones. Here we outline approaches for the appropriate culturing of mammospheres from cell lines or primary patient samples, their passaging, and calculations to estimate sphere forming efficiency (SFE). First we discuss key considerations and pitfalls in the appropriate planning and interpretation of mammosphere experiments.
Related Papers
- → ALDH1+ stem cells demonstrate more stem cell-like characteristics than CD44+/CD24–/low stem cells in different molecular subtypes of breast cancer(2020)18 cited
- → Increased invasion and tumorigenicity capacity of CD44+/CD24- breast cancer MCF7 cells in vitro and in nude mice(2013)66 cited
- → CD26 a cancer stem cell marker and therapeutic target(2015)46 cited
- → The CD44std and CD44v9 subpopulations in non-tumorigenic invasive SNU-423 cells present different features of cancer stem cells(2023)3 cited
- Breast Cancer Stem Cell Involves Distant Metastasis Through Epithelial-Mesenchymal Transition Induced by Up-Regulating Twist Expression(2010)